Social News
Written by: Zheng Cuibi Zhu Haiqi
2021-03-28 15:52
Last update date: 2021-03-28 15:52
The vaccination of Fubitai vaccine was stopped due to problems such as displacement of the bottle cover.
The German pharmaceutical company BioNTech and Fosun Pharma responded to "Hong Kong 01". They have recalled all defective vaccines and are evaluating delivery of another batch of vaccines to Hong Kong and Macau to resume the vaccination plan.
And Baxter, another pharmaceutical company, also confirmed that it will assist BioNTech in the production of the new crown vaccine, which is produced in Halle Westfalen, Germany.
▼On February 27, the first batch of Fubitai vaccine was delivered to Hong Kong▼
+13
+13
+13
Fosun Pharma stated that a small number of Hong Kong and Macau Fubitai vaccine vials had defective seals. An interim survey result report has been provided to further confirm that it is only related to vaccine packaging related to transportation conditions, the production process of the vaccine, and the production process of the vaccine. There was no problem with the quality. When the problem was discovered, a notice of suspension of vaccination was immediately issued to Hong Kong and Macau, and all vaccines with defective bottle caps were recalled.
In order to restart the vaccination program in time, Fosun said it is evaluating the delivery of another batch of vaccines to Hong Kong and Macau.
In response, Baxter confirmed that it would assist BioNTech in producing the new crown vaccine, which came from Westphalia, Germany. Since the agreement has been signed, it is inconvenient to disclose the details.
▼Professor Yuan Guoyong injected himself with Fubitai vaccine▼
+4
+4
+4
Fubitai suspends | Investigation is expected to be completed in one week Xu Shuchang: Or increase inoculation centers to catch up
Fubitel Vaccine Suspension | Preliminary investigation does not involve safety and does not rule out packaging defects caused by long-distance transportation
Fubitai Vaccine｜Nie Dequan: I hope to know whether the second injection can be resumed next week and citizens will be given priority
01News
New Coronary Pneumonia New Coronary Vaccine Fubitai Vaccine
